Phospholipase A2 C

Unless otherwise stated all data on this page refer to the human proteins. Gene information is provided for human (Hs), mouse (Mm) and rat (Rn).

Overview

« Hide

Phospholipase A2 (PLA2, EC 3.1.1.4) cleaves the sn-2 fatty acid of phospholipids, primarily phosphatidylcholine, to generate lysophosphatidylcholine and arachidonic acid. Most commonly-used inhibitors (e.g. bromoenol lactone, arachidonyl trifluoromethyl ketone or methyl arachidonyl fluorophosphonate) are either non-selective within the family of phospholipase A2 enzymes or have activity against other eicosanoid-metabolising enzymes.

Secreted or extracellular forms: sPLA2-1B, sPLA2-2A, sPLA2-2D, sPLA2-2E, sPLA2-2F, sPLA2-3, sPLA2-10 and sPLA2-12A

Cytosolic, calcium-dependent forms: cPLA2-4A, cPLA2-4B, cPLA2-4C, cPLA2-4D, cPLA2-4E and cPLA2-4F

Other forms: PLA2-G5, iPLA2-G6, PLA2-G7 and PAFAH2 (platelet-activating factor acetylhydrolase 2)

Enzymes

sPLA2-1B C Show summary » More detailed page

sPLA2-2D C Show summary »

sPLA2-2E C Show summary »

sPLA2-2F C Show summary »

sPLA2-2A C Show summary » More detailed page

PLA2-G7 C Show summary » More detailed page

sPLA2-3 C Show summary »

sPLA2-10 C Show summary »

sPLA2-12A C Show summary »

cPLA2-4A C Show summary » More detailed page

cPLA2-4B C Show summary »

cPLA2-4C C Show summary »

cPLA2-4D C Show summary »

cPLA2-4E C Show summary »

cPLA2-4F C Show summary »

PLA2-G5 C Show summary »

iPLA2-G6 C Show summary »

platelet activating factor acetylhydrolase 2 C Show summary »

Comments

Show »

References

Show »

How to cite this family page

Database page citation:

Phospholipase A2. Accessed on 27/03/2017. IUPHAR/BPS Guide to PHARMACOLOGY, http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=275.

Concise Guide to PHARMACOLOGY citation:

Alexander SPH, Fabbro D, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Southan C, Davies JA and CGTP Collaborators (2015) The Concise Guide to PHARMACOLOGY 2015/16: Enzymes. Br J Pharmacol. 172: 6024-6109.